After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55 a.m. EDT on Monday.
After the small-cap medical device company announced the Food and Drug Administration approval of its Senhance Surgical Robotic System, shares of TransEnterix (NYSEMKT: TRXC) jumped 75% as of 9:55 a.m. EDT on Monday.